STOCK TITAN
  1. Home
  2. Sec-filings
  3. HCWB
  4. [EFFECT] HCW Biologics Inc. SEC Filing

[EFFECT] HCW Biologics Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: January 29, 2026 3:00 P.M.
Form: S-1
CIK: 0001828673
Company Name: HCW Biologics Inc.
File Number: 333-292652

Source: View Original Filing on SEC EDGAR

Stock HCWB logo
Hcw Biologics Inc.

NASDAQ:HCWB

HCWB Rankings

#6751 Ranked by Market Cap
N/A Ranked by Dividends

HCWB Latest News

Nov 19, 2025
HCW Biologics Enters into $4.0 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules
Nov 18, 2025
HCW Biologics Announces Initiation of First-In-Human Clinical Trial to Evaluate HCW9302 in an Autoimmune Disease
Nov 14, 2025
HCW Biologics Reports Third Quarter 2025 Business Highlights and Financial Results
Nov 10, 2025
HCW Biologics Shares the Latest Data for its Second-Generation Immune Checkpoint Inhibitor Presented at the 40th Annual Meeting of the Society for Immunotherapy of Cancer
Nov 7, 2025
HCW Biologics Presents Preclinical Data for TRBC-Based T-Cell Engager Program at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting

HCWB Latest SEC Filings

Jan 9, 2026
[S-1] HCW Biologics Inc. Files IPO Registration Statement
Nov 20, 2025
[8-K] HCW Biologics Inc. Reports Material Event
Nov 18, 2025
[8-K] HCW Biologics Inc. Reports Material Event
Nov 18, 2025
[8-K] HCW Biologics Inc. Reports Material Event
Oct 16, 2025
[8-K] HCW Biologics Inc. Reports Material Event

HCWB Stock Data

3.64M
2.69M
27.3%
1%
11.41%
Biotechnology
Pharmaceutical Preparations
Link
United States
MIRAMAR